New Assays for Expression Profiling of MicroRNAs

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41HG008247-01A1
Agency Tracking Number: R41HG008247
Amount: $224,951.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: 172
Solicitation Number: PA14-072
Timeline
Solicitation Year: 2015
Award Year: 2015
Award Start Date (Proposal Award Date): 2015-04-01
Award End Date (Contract End Date): 2017-03-31
Small Business Information
4320 FOREST PARK AVE, STE 303, Saint Louis, MO, 63108-2979
DUNS: 078644885
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 WEIJUN LIU
 (314) 362-9772
 wliu@radonc.wustl.edu
Business Contact
 XIAOBING BE
Phone: (314) 540-8949
Email: xbe@nawgen.com
Research Institution
 WASHINGTON UNIVERSITY
 Campus Box 1054
1 Brookings Drive
SAINT LOUIS, MO, 63130-4862
 Nonprofit college or university
Abstract
DESCRIPTION provided by applicant MicroRNAs miRNAs are involved in many diverse biological processes and a single miRNA can modulate the expression of hundreds of gene targets Changes in miRNA expression could have profound biological impacts leading to a variety of human diseases To date most miRNA expression profiling studies have relied on microarrays or high throughput RNA sequencing RNA seq For these high throughput experiments it is important to validate the profiling results with independent methods Real time PCR is considered as the gold standard for gene expression quantification and thus is ideal for validation of microarray or RNA seq results Furthermore despite their wide use for miRNA profiling there are some major limitations associated with microarrays and RNA seq such as the requirement of high quality RNA samples To address these issues we have developed a new real time RT PCR method With this new method we have profiled the expression of cancer related miRNAs in hundreds of archived tumor tissues and identified novel miRNA signatures as predictive biomarkers for multiple types of cancer Building on the success of our new method for cancer related miRNA profiling we propose to significantly expand the scope of the method by designing and testing new assays to encompass all known miRNAs in the human genome Specific Aim These miRNA assays will serve two main purposes As a reliable independent method for validation of high throughput results from microarrays or RNA seq and expression profiling of low quality degraded RNA extracted from clinical tissues In both cases availability of these miRNA assays will enable researchers to correlate abnormal miRNA expression changes to human diseases by focusing on a selected set of miRNAs To facilitate the selection of miRNA assays by end users we also propose to establish an online database to present experimentally validated assays for all known human miRNAs Specific Aim PUBLIC HEALTH RELEVANCE MicroRNAs miRNAs are involved in many diverse biological processes and changes in miRNA expression lead to various human diseases One major challenge in this field is the lack of assays for miRNA expression profiling analysis To address this issue we propose to develop new assay products to profile miRNA expression changes related to human diseases

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government